14-24307385-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The ENST00000554411.6(CIDEB):c.172G>A(p.Glu58Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000039 in 1,613,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E58G) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000554411.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIDEB | NM_001393339.1 | c.172G>A | p.Glu58Lys | missense_variant | 2/5 | ENST00000554411.6 | NP_001380268.1 | |
NOP9 | NM_174913.3 | c.*2290C>T | 3_prime_UTR_variant | 10/10 | ENST00000267425.8 | NP_777573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIDEB | ENST00000554411.6 | c.172G>A | p.Glu58Lys | missense_variant | 2/5 | 1 | NM_001393339.1 | ENSP00000451089 | P1 | |
NOP9 | ENST00000267425.8 | c.*2290C>T | 3_prime_UTR_variant | 10/10 | 1 | NM_174913.3 | ENSP00000267425 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 251024Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135664
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461392Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726972
GnomAD4 genome AF: 0.000138 AC: 21AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.172G>A (p.E58K) alteration is located in exon 4 (coding exon 2) of the CIDEB gene. This alteration results from a G to A substitution at nucleotide position 172, causing the glutamic acid (E) at amino acid position 58 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at